How does pre-transplant MRD affect outcome in AML?

How does pretransplant 𝘐𝘋𝘏1 and 𝘐𝘋𝘏2 MRD affect posttransplant outcomes in patients with AML?Подробнее

Sanam Loghavi MD - Virtual Pathology Grand Rounds - April 9, 2020Подробнее

The prognostic impact of pre-transplant MRD-positivity in patients with AMLПодробнее

Predictors of outcomes in post-transplant patients with AMLПодробнее

Optimising transplant outcome in adults allografted for AMLПодробнее

What time is the right time for transplantation?Подробнее

Should pre-transplant MRD be used to guide treatment in AML?Подробнее

MRD in Acute Myeloid LeukemiaПодробнее

Pre-transplant MRD status by NGS as a prognostic tool for AML and MDSПодробнее

Significance of Minimal Residual Disease in Acute Myeloid LeukemiaПодробнее

MRD in AML: What is it and what do I do about it?Подробнее

Indications for allogeneic stem cell transplantation in AMLПодробнее

FLAMSU-Bu conditioning doesn't improve outcome in AML/MDS irrespective of pre-transplant MRD statusПодробнее

MRD Monitoring in Acute Myeloid LeukemiaПодробнее

What impact does MRD status have on the outcomes of patients with AML undergoing allo-SCT?Подробнее